| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |